Erratum for

• DREADD: a chemogenetic GPCR signaling platform.

  Zhu H, Roth BL. Zhu H, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu007. doi: 10.1093/ijnp/pyu007. Int J Neuropsychopharmacol. 2014. PMID: 25522378 Free PMC article.
• Effects of α-pyrrolidinopentiophenone and 4-methyl-N-ethylcathinone, two synthetic cathinones commonly found in second-generation "bath salts," on intracranial self-stimulation thresholds in rats.

  Watterson LR, Burrows BT, Hernandez RD, Moore KN, Grabenauer M, Marusich JA, Olive MF. Watterson LR, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu014. doi: 10.1093/ijnp/pyu014. Int J Neuropsychopharmacol. 2014. PMID: 25522379 Free PMC article.
• Chronic stimulation of the tone of endogenous anandamide reduces cue- and stress-induced relapse in rats.

  Chauvet C, Nicolas C, Thiriet N, Lardeux MV, Duranti A, Solinas M. Chauvet C, et al. Int J Neuropsychopharmacol. 2014 Dec 5;18(1):pyu025. doi: 10.1093/ijnp/pyu025. Int J Neuropsychopharmacol. 2014. PMID: 25522382 Free PMC article.
• Familial risk for major depression is associated with lower striatal 5-HT₄ receptor binding.

  Madsen K, Torstensen E, Holst KK, Haahr ME, Knorr U, Frokjaer VG, Brandt-Larsen M, Iversen P, Fisher PM, Knudsen GM. Madsen K, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu034. doi: 10.1093/ijnp/pyu034. Int J Neuropsychopharmacol. 2014. PMID: 25522384 Free PMC article.
• Hypothalamic-pituitary-adrenal axis dysfunction and illness progression in bipolar disorder.

  Fries GR, Vasconcelos-Moreno MP, Gubert C, dos Santos BT, Sartori J, Eisele B, Ferrari P, Fijtman A, Rüegg J, Gassen NC, Kapczinski F, Rein T, Kauer-Sant'Anna M. Fries GR, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu043. doi: 10.1093/ijnp/pyu043. Int J Neuropsychopharmacol. 2014. PMID: 25522387 Free PMC article.
• A randomized controlled trial of brief and ultrabrief pulse right unilateral electroconvulsive therapy.

  Loo CK, Katalinic N, Smith DJ, Ingram A, Dowling N, Martin D, Addison K, Hadzi-Pavlovic D, Simpson B, Schweitzer I. Loo CK, et al. Int J Neuropsychopharmacol. 2014 Dec 5;18(1):pyu045. doi: 10.1093/ijnp/pyu045. Int J Neuropsychopharmacol. 2014. PMID: 25522389 Free PMC article. Clinical Trial.
• Carrier-mediated cocaine transport at the blood-brain barrier as a putative mechanism in addiction liability.

  Chapy H, Smirnova M, André P, Schlatter J, Chiadmi F, Couraud PO, Scherrmann JM, Declèves X, Cisternino S. Chapy H, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu001. doi: 10.1093/ijnp/pyu001. Int J Neuropsychopharmacol. 2014. PMID: 25539501 Free PMC article.
• Lipopolysaccharide-induced depressive-like behavior is associated with α₁-adrenoceptor dependent downregulation of the membrane GluR1 subunit in the mouse medial prefrontal cortex and ventral tegmental area.

  Sekio M, Seki K. Sekio M, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu005. doi: 10.1093/ijnp/pyu005. Int J Neuropsychopharmacol. 2014. PMID: 25539502 Free PMC article.
• Dopamine and glutamate interaction mediates reinstatement of drug-seeking behavior by stimulation of the ventral subiculum.

  Taepavarapruk P, Butts KA, Phillips AG. Taepavarapruk P, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu008. doi: 10.1093/ijnp/pyu008. Int J Neuropsychopharmacol. 2014. PMID: 25539503 Free PMC article.
• Oxytocin reduces cocaine seeking and reverses chronic cocaine-induced changes in glutamate receptor function.

  Zhou L, Sun WL, Young AB, Lee K, McGinty JF, See RE. Zhou L, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu009. doi: 10.1093/ijnp/pyu009. Int J Neuropsychopharmacol. 2014. PMID: 25539504 Free PMC article.
• Targeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders.

  Wesseling H, Gottschalk MG, Bahn S. Wesseling H, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu015. doi: 10.1093/ijnp/pyu015. Int J Neuropsychopharmacol. 2014. PMID: 25539505 Free PMC article.
• Monocyte and lymphocyte activation in bipolar disorder: a new piece in the puzzle of immune dysfunction in mood disorders.

  Barbosa IG, Rocha NP, Assis F, Vieira ÉL, Soares JC, Bauer ME, Teixeira AL. Barbosa IG, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu021. doi: 10.1093/ijnp/pyu021. Int J Neuropsychopharmacol. 2014. PMID: 25539506 Free PMC article.
• Cerebrospinal fluid neuropeptide Y levels in major depression and reported childhood trauma.

  Soleimani L, Oquendo MA, Sullivan GM, Mathé AA, Mann JJ. Soleimani L, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu023. doi: 10.1093/ijnp/pyu023. Int J Neuropsychopharmacol. 2014. PMID: 25539507 Free PMC article.
• Cocaine-induced behavioral sensitization is associated with changes in the expression of endocannabinoid and glutamatergic signaling systems in the mouse prefrontal cortex.

  Blanco E, Pavón FJ, Palomino A, Luque-Rojas MJ, Serrano A, Rivera P, Bilbao A, Alen F, Vida M, Suárez J, Rodríguez de Fonseca F. Blanco E, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu024. doi: 10.1093/ijnp/pyu024. Int J Neuropsychopharmacol. 2014. PMID: 25539508 Free PMC article.
• PTSD-like memory generated through enhanced noradrenergic activity is mitigated by a dual step pharmacological intervention targeting its reconsolidation.

  Gazarini L, Stern CA, Piornedo RR, Takahashi RN, Bertoglio LJ. Gazarini L, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu026. doi: 10.1093/ijnp/pyu026. Int J Neuropsychopharmacol. 2014. PMID: 25539509 Free PMC article.
• BDNF release is required for the behavioral actions of ketamine.

  Lepack AE, Fuchikami M, Dwyer JM, Banasr M, Duman RS. Lepack AE, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu033. doi: 10.1093/ijnp/pyu033. Int J Neuropsychopharmacol. 2014. PMID: 25539510 Free PMC article.
• Increasing endocannabinoid levels in the ventral pallidum restore aberrant dopamine neuron activity in the subchronic PCP rodent model of schizophrenia.

  Aguilar DD, Chen L, Lodge DJ. Aguilar DD, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu035. doi: 10.1093/ijnp/pyu035. Int J Neuropsychopharmacol. 2014. PMID: 25539511 Free PMC article.
• Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.

  Niciu MJ, Luckenbaugh DA, Ionescu DF, Richards EM, Vande Voort JL, Ballard ED, Brutsche NE, Furey ML, Zarate CA Jr. Niciu MJ, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(1):pyu039. doi: 10.1093/ijnp/pyu039. Int J Neuropsychopharmacol. 2014. PMID: 25539512 Free PMC article. Clinical Trial.
• Impaired limbic cortico-striatal structure and sustained visual attention in a rodent model of schizophrenia.

  Barnes SA, Sawiak SJ, Caprioli D, Jupp B, Buonincontri G, Mar AC, Harte MK, Fletcher PC, Robbins TW, Neill JC, Dalley JW. Barnes SA, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(2):pyu010. doi: 10.1093/ijnp/pyu010. Int J Neuropsychopharmacol. 2014. PMID: 25552430 Free PMC article.
• Acute nicotine administration increases BOLD fMRI signal in brain regions involved in reward signaling and compulsive drug intake in rats.

  Bruijnzeel AW, Alexander JC, Perez PD, Bauzo-Rodriguez R, Hall G, Klausner R, Guerra V, Zeng H, Igari M, Febo M. Bruijnzeel AW, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(2):pyu011. doi: 10.1093/ijnp/pyu011. Int J Neuropsychopharmacol. 2014. PMID: 25552431 Free PMC article.
• Effects of oxytocin on attention to emotional faces in healthy volunteers and highly socially anxious males.

  Clark-Elford R, Nathan PJ, Auyeung B, Mogg K, Bradley BP, Sule A, Müller U, Dudas RB, Sahakian BJ, Baron-Cohen S. Clark-Elford R, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(2):pyu012. doi: 10.1093/ijnp/pyu012. Int J Neuropsychopharmacol. 2014. PMID: 25552432 Free PMC article. Clinical Trial.
• Prefrontal cortical GABA modulation of spatial reference and working memory.

  Auger ML, Floresco SB. Auger ML, et al. Int J Neuropsychopharmacol. 2014 Oct 31;18(2):pyu013. doi: 10.1093/ijnp/pyu013. Int J Neuropsychopharmacol. 2014. PMID: 25552433 Free PMC article.
• Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans.

  Dolder PC, Schmid Y, Haschke M, Rentsch KM, Liechti ME. Dolder PC, et al. Int J Neuropsychopharmacol. 2015 Jun 24;19(1):pyv072. doi: 10.1093/ijnp/pyv072. Int J Neuropsychopharmacol. 2015. PMID: 26108222 Free PMC article. Clinical Trial.
• Candidate Risks Indicators for Bipolar Disorder: Early Intervention Opportunities in High-Risk Youth.

  Duffy A, Jones S, Goodday S, Bentall R. Duffy A, et al. Int J Neuropsychopharmacol. 2015 Jun 25;19(1):pyv071. doi: 10.1093/ijnp/pyv071. Int J Neuropsychopharmacol. 2015. PMID: 26116493 Free PMC article. Review.
• Waiting Impulsivity: The Influence of Acute Methylphenidate and Feedback.

  Voon V, Chang-Webb YC, Morris LS, Cooper E, Sethi A, Baek K, Grant J, Robbins TW, Harrison NA. Voon V, et al. Int J Neuropsychopharmacol. 2015 Jun 30;19(1):pyv074. doi: 10.1093/ijnp/pyv074. Int J Neuropsychopharmacol. 2015. PMID: 26136351 Free PMC article. Clinical Trial.
• Prevention of Relapse and Recurrence in Adults with Major Depressive Disorder: Systematic Review and Meta-Analyses of Controlled Trials.

  Sim K, Lau WK, Sim J, Sum MY, Baldessarini RJ. Sim K, et al. Int J Neuropsychopharmacol. 2015 Jul 7;19(2):pyv076. doi: 10.1093/ijnp/pyv076. Int J Neuropsychopharmacol. 2015. PMID: 26152228 Free PMC article.
• Regulation of Pleiotrophin, Midkine, Receptor Protein Tyrosine Phosphatase β/ζ, and Their Intracellular Signaling Cascades in the Nucleus Accumbens During Opiate Administration.

  García-Pérez D, Laorden ML, Milanés MV. García-Pérez D, et al. Int J Neuropsychopharmacol. 2015 Jul 11;19(1):pyv077. doi: 10.1093/ijnp/pyv077. Int J Neuropsychopharmacol. 2015. PMID: 26164717 Free PMC article.
• Suicide Behavior Before and After the Start with Antidepressants: A High Persistent Risk in the First Month of Treatment Among the Young.

  Termorshuizen F, Palmen SJ, Heerdink ER. Termorshuizen F, et al. Int J Neuropsychopharmacol. 2015 Jul 18;19(2):pyv081. doi: 10.1093/ijnp/pyv081. Int J Neuropsychopharmacol. 2015. PMID: 26188343 Free PMC article.
• The Cognitive Effects of Antidepressants in Major Depressive Disorder: A Systematic Review and Meta-Analysis of Randomized Clinical Trials.

  Rosenblat JD, Kakar R, McIntyre RS. Rosenblat JD, et al. Int J Neuropsychopharmacol. 2015 Jul 25;19(2):pyv082. doi: 10.1093/ijnp/pyv082. Int J Neuropsychopharmacol. 2015. PMID: 26209859 Free PMC article.
• Local and Global Resting State Activity in the Noradrenergic and Dopaminergic Pathway Modulated by Reboxetine and Amisulpride in Healthy Subjects.

  Metzger CD, Wiegers M, Walter M, Abler B, Graf H. Metzger CD, et al. Int J Neuropsychopharmacol. 2015 Jul 25;19(2):pyv080. doi: 10.1093/ijnp/pyv080. Int J Neuropsychopharmacol. 2015. PMID: 26209860 Free PMC article. Clinical Trial.
• Intravenous Clomipramine for Treatment-Resistant Obsessive-Compulsive Disorder.

  Karameh WK, Khani M. Karameh WK, et al. Int J Neuropsychopharmacol. 2015 Jul 28;19(2):pyv084. doi: 10.1093/ijnp/pyv084. Int J Neuropsychopharmacol. 2015. PMID: 26221004 Free PMC article. Clinical Trial.
• Cholinesterase Inhibitors for Lewy Body Disorders: A Meta-Analysis.

  Matsunaga S, Kishi T, Yasue I, Iwata N. Matsunaga S, et al. Int J Neuropsychopharmacol. 2015 Jul 28;19(2):pyv086. doi: 10.1093/ijnp/pyv086. Int J Neuropsychopharmacol. 2015. PMID: 26221005 Free PMC article. Review.
• 12-Deoxyphorbols Promote Adult Neurogenesis by Inducing Neural Progenitor Cell Proliferation via PKC Activation.

  Geribaldi-Doldán N, Flores-Giubi E, Murillo-Carretero M, García-Bernal F, Carrasco M, Macías-Sánchez AJ, Domínguez-Riscart J, Verástegui C, Hernández-Galán R, Castro C. Geribaldi-Doldán N, et al. Int J Neuropsychopharmacol. 2015 Jul 29;19(1):pyv085. doi: 10.1093/ijnp/pyv085. Int J Neuropsychopharmacol. 2015. PMID: 26224011 Free PMC article.
• Prefrontal microRNA-221 Mediates Environmental Enrichment-Induced Increase of Locomotor Sensitivity to Nicotine.

  Gomez AM, Altomare D, Sun WL, Midde NM, Ji H, Shtutman M, Turner JR, Creek KE, Zhu J. Gomez AM, et al. Int J Neuropsychopharmacol. 2015 Aug 1;19(1):pyv090. doi: 10.1093/ijnp/pyv090. Int J Neuropsychopharmacol. 2015. PMID: 26232787 Free PMC article.
• Impaired 2-AG Signaling in Hippocampal Glutamatergic Neurons: Aggravation of Anxiety-Like Behavior and Unaltered Seizure Susceptibility.

  Guggenhuber S, Romo-Parra H, Bindila L, Leschik J, Lomazzo E, Remmers F, Zimmermann T, Lerner R, Klugmann M, Pape HC, Lutz B. Guggenhuber S, et al. Int J Neuropsychopharmacol. 2015 Aug 1;19(2):pyv091. doi: 10.1093/ijnp/pyv091. Int J Neuropsychopharmacol. 2015. PMID: 26232789 Free PMC article.
• Quetiapine Ameliorates Schizophrenia-Like Behaviors and Protects Myelin Integrity in Cuprizone Intoxicated Mice: The Involvement of Notch Signaling Pathway.

  Wang HN, Liu GH, Zhang RG, Xue F, Wu D, Chen YC, Peng Y, Peng ZW, Tan QR. Wang HN, et al. Int J Neuropsychopharmacol. 2015 Aug 1;19(2):pyv088. doi: 10.1093/ijnp/pyv088. Int J Neuropsychopharmacol. 2015. PMID: 26232790 Free PMC article.
• Two Binges of Ethanol a Day Keep the Memory Away in Adolescent Rats: Key Role for GLUN2B Subunit.

  Silvestre de Ferron B, Bennouar KE, Kervern M, Alaux-Cantin S, Robert A, Rabiant K, Antol J, Naassila M, Pierrefiche O. Silvestre de Ferron B, et al. Int J Neuropsychopharmacol. 2015 Aug 6;19(1):pyv087. doi: 10.1093/ijnp/pyv087. Int J Neuropsychopharmacol. 2015. PMID: 26254123 Free PMC article.
• Magnetoencephalographic Correlates of Emotional Processing in Major Depression Before and After Pharmacological Treatment.

  Domschke K, Zwanzger P, Rehbein MA, Steinberg C, Knoke K, Dobel C, Klinkenberg I, Kugel H, Kersting A, Arolt V, Pantev C, Junghofer M. Domschke K, et al. Int J Neuropsychopharmacol. 2015 Aug 9;19(2):pyv093. doi: 10.1093/ijnp/pyv093. Int J Neuropsychopharmacol. 2015. PMID: 26259960 Free PMC article.
• Monoamine Oxidase-A Occupancy by Moclobemide and Phenelzine: Implications for the Development of Monoamine Oxidase Inhibitors.

  Chiuccariello L, Cooke RG, Miler L, Levitan RD, Baker GB, Kish SJ, Kolla NJ, Rusjan PM, Houle S, Wilson AA, Meyer JH. Chiuccariello L, et al. Int J Neuropsychopharmacol. 2015 Aug 27;19(1):pyv078. doi: 10.1093/ijnp/pyv078. Int J Neuropsychopharmacol. 2015. PMID: 26316187 Free PMC article.
• The CB1 Neutral Antagonist Tetrahydrocannabivarin Reduces Default Mode Network and Increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers.

  Rzepa E, Tudge L, McCabe C. Rzepa E, et al. Int J Neuropsychopharmacol. 2015 Sep 10;19(2):pyv092. doi: 10.1093/ijnp/pyv092. Int J Neuropsychopharmacol. 2015. PMID: 26362774 Free PMC article. Clinical Trial.
• Hippocampal PPARδ Overexpression or Activation Represses Stress-Induced Depressive Behaviors and Enhances Neurogenesis.

  Ji MJ, Yu XB, Mei ZL, An YQ, Tang SS, Hu M, Long Y, Miao MX, Hu QH, Sun HB, Kong LY, Hong H. Ji MJ, et al. Int J Neuropsychopharmacol. 2015 Sep 10;19(1):pyv083. doi: 10.1093/ijnp/pyv083. Int J Neuropsychopharmacol. 2015. PMID: 26362775 Free PMC article.
• Quantitative Proteomic Analysis Reveals Molecular Adaptations in the Hippocampal Synaptic Active Zone of Chronic Mild Stress-Unsusceptible Rats.

  Zhou J, Liu Z, Yu J, Han X, Fan S, Shao W, Chen J, Qiao R, Xie P. Zhou J, et al. Int J Neuropsychopharmacol. 2015 Sep 12;19(1):pyv100. doi: 10.1093/ijnp/pyv100. Int J Neuropsychopharmacol. 2015. PMID: 26364272 Free PMC article.
• Clarifying the Mechanisms of Antidepressants.

  Tucker DM. Tucker DM. Int J Neuropsychopharmacol. 2015 Sep 12;19(1):pyv104. doi: 10.1093/ijnp/pyv104. Int J Neuropsychopharmacol. 2015. PMID: 26364277 Free PMC article. No abstract available.
• Insulin-Like Growth Factor I Produces an Antidepressant-Like Effect and Elicits N-Methyl-D-Aspartate Receptor Independent Long-Term Potentiation of Synaptic Transmission in Medial Prefrontal Cortex and Hippocampus.

  Burgdorf J, Zhang XL, Colechio EM, Ghoreishi-Haack N, Gross A, Kroes RA, Stanton PK, Moskal JR. Burgdorf J, et al. Int J Neuropsychopharmacol. 2015 Sep 15;19(2):pyv101. doi: 10.1093/ijnp/pyv101. Int J Neuropsychopharmacol. 2015. PMID: 26374350 Free PMC article.
• Leptin/LepRb in the Ventral Tegmental Area Mediates Anxiety-Related Behaviors.

  Liu J, Guo M, Lu XY. Liu J, et al. Int J Neuropsychopharmacol. 2015 Oct 5;19(2):pyv115. doi: 10.1093/ijnp/pyv115. Int J Neuropsychopharmacol. 2015. PMID: 26438799 Free PMC article.